Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Dylan Carroll

Colon & Rectal Surgery Springfield, MO Medical Doctor

NPI 1881198497 CMS profile 11305608

1001 E Primrose St Fl 2, Springfield, MO 65807

Open in the dashboard

General payments

$1,611

20 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dylan Carroll of Springfield, MO is reported in the CMS Open Payments database as having received $1,611 across 20 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 39th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,126 10
2024 General $147 4
2023 General $160 2
2022 General $22 1
2021 General $157 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dylan Carroll
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Dylan Carroll were reported at $1,126. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Dylan Carroll Colon & Rectal Surgery median Middle half National median
2019 $0 $443 $125–$2,179 $163
2020 $0 $167 $53–$931 $114
2021 $157 $207 $72–$1,272 $132
2022 $22 $341 $111–$1,587 $149
2023 $160 $322 $115–$1,420 $160
2024 $147 $328 $112–$1,354 $164
2025 $1,126 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $877 1 payment
  2. Medtronic, Inc. $215 3 payments
  3. Boston Scientific Corporation $183 6 payments
  4. Standard Bariatrics, Inc. $119 1 payment
  5. Baxter Healthcare $65 2 payments
  6. Acera Surgical, Inc. $27 1 payment
  7. Cerus Corporation $24 1 payment
  8. Terumo Medical Corporation $22 1 payment
  9. Axonics Modulation Technologies, Inc. $21 1 payment
  10. PolyNovo North America LLC $19 1 payment
  11. Other $38 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $1,017 3 payments
  2. Food and Beverage $594 17 payments
Products named General payments · program years 2021–2025
  1. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $877 1 payment
  2. Axonics $204 7 payments
  3. Signia $136 1 payment
  4. TITAN SGS STANDARD GASTRIC STAPLER $119 1 payment
  5. TISSEEL $65 2 payments
  6. LigaSure $60 1 payment
  7. Restrata Wound Matrix $27 1 payment
  8. INTERCEPT BLOOD SYSTEM FOR PLATELETS $24 1 payment
  9. Azur CX Detachable $22 1 payment
  10. NOVOSORB BTM $19 1 payment
  11. Other $57 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

60

Median for Colorectal Surgery (Proctology): 106

Drug cost

$115

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

0%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 16 $58
Gabapentin Generic 16 $48
Metoclopramide Hcl Generic 28 $8

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$6,852

Medicare's payments for the services billed

Medicare patients

45

Average age 72

Services billed

66

17 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Chronic kidney disease 42%
Arthritis 42%
Cancer 36%
Diabetes 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

20 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record